Under construction – not a live service
Sign in
Taking people in ItalyNo phase

Studies young adults under 40 with melanoma skin cancer

Observes adults aged 18 to 39 with melanoma, looking at its features and risk factors.

Plain-language title generated from the registry record
Registry title: Characteristics of Adult Patients With Melanoma Diagnosis <40 Years Age.

Key facts

Where
Genoa, ItalySee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 39 years old?

Source: NCT06994208, who can take part

Where in Italy

  • E.O. Ospedali GallieraGenoa, ItalyTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Ente Ospedaliero Ospedali Galliera
Trial code
NCT06994208
Record updated
19 December 2025
Original description
The primary objective of the study is to analyse a local cohort of patients aged 18-39 years with melanoma diagnosis in order to determine the prevalence of the disease in this age group.Read full original descriptionShow less

Demographic, Clinical, Dermoscopic, Phenotypic and Genetic Characteristics of Adult Patients With Melanoma Diagnosis <40 Years Age. A Prospective, Monocentric Observational Study

The primary objective of the study is to analyse a local cohort of patients aged 18-39 years with melanoma diagnosis in order to determine the prevalence of the disease in this age group.

Secondary objectives are the following:

* To identify risk factors associated with melanoma in young people. * To characterise the phenotype and dermoscopic features of melanoma in patients aged 18-39 years. * To analyse the relationship between the clinical and histopathological features of melanoma in young people. * To identify the mutational status of B-RAF in the sample of patients analysed.

Inclusion: written informed consent; age > 18 years and < 40 years; diagnosis of cutaneous melanoma even non-primary.

Exclusion: -.

ClinicalTrials.gov NCT06994208